Plasma osteopontin in comparison with bone markers as an indicator of distant metastases and a predictor of survival outcome in prostate cancer and renal cell carcinoma patients [Elektronische Ressource] / Azizbek Ramankulov

Aus der Klinik für Urologie, Campus Charité Mitte der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION Plasma osteopontin in comparison with bone markers as an indicator of distant metastases and a predictor of survival outcome in prostate cancer and renal cell carcinoma patients zur Erlangung des akademischen Grades Doctor medicinae (Dr. med.) vorgelegt der Medizinischen Fakultät Charité – Universitätsmedizin Berlin von Azizbek Ramankulov aus Bischkek, Kirgisien Gutachter: 1. Prof. Dr. med. K. Jung 2. Prof. Dr. med. D. Fahlenkamp 3. Priv.-Doz. Dr. med. A. Sokolowski Datum der Promotion: 22. Juni 2007 Parts of this dissertation have been published or submitted for publication in the following articles: 1. Ramankulov A, Michael R, Lein M, Loening SA, Jung K. Bone turnover markers as diagnostic and prognostic tools in metastatic renal cell carcinoma. Central As Med J 2006;12:97-101. 2. Ramankulov A, Lein M, Kristiansen G, Loening SA, Jung K. Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer. Prostate 2007;67:330-340. 3. Ramankulov A, Lein M, Kristiansen G, Meyer H-A, Loening SA, Jung K.